TELL A FRIEND ABOUT OSMOPREP Mail a Friend

Send a friend a link to this page.

Your Name:
Your E-mail:
Friend's Name:
Friend's E-mail:

Send me a copy of this e-mail
Send me updates about OsmoPrep

ARE YOU AT RISK FOR COLON CANCER?

TAKE THE RISK ASSESSMENT NOW

Print this page:

Font Size:

What is a colonoscopy?

In order to view the entire lining of the colon and rectum , a colonoscopy is performed by a healthcare professional, usually a gastroenterologist. The routine procedure is quick, with little discomfort, and provides an unobstructed view of the colon. Colonoscopies are usually performed as an outpatient procedure.

A colonoscopy is generally recommended when at least one of the following has occurred: bowel habits change, blood in stool, persistent abdominal pain, or the patient is aged 50 years or older. Colonoscopies are one of the best tools healthcare professionals have to detect colon cancer as well as diagnose other gastrointestinal issues.

Roll over the icons below to display more information (Flash player required).

Click here to download the full poster.

It is recommended that anyone over the age of 50 has a colonoscopy performed every 10 years. People with a higher risk of colon cancer may have more frequent colonoscopies performed depending on their healthcare professional’s advice.

When you talk to your healthcare provider about your screening, be sure to discuss which colonoscopy prep is right for you—there are many choices. Ask about OsmoPrep and how it may change your colonoscopy experience. OsmoPrep Tablets represent the latest advancement in the evolution of colonoscopy preps. Because it’s a virtually tasteless tablet and not a liquid, you taste the clear liquid with which you choose to take it—not the prep.

If you are scheduled to have a colonoscopy, over 50, or think you may need one, ask your healthcare provider TODAY about OsmoPrep and how it can change the prepping procedure.

What happens during a colonoscopy procedure?

Colonoscopy preparation tips.

What is colon cancer?

What puts you at risk for colon cancer?

Learn about the colonoscopy prep that’s a pill not a liquid—OsmoPrep.

Important Safety Information about OsmoPrep

WARNINGS

There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long–term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include those with increased age, hypovolemia, increased bowel transit time (such as bowel obstruction), active colitis, or baseline kidney disease, and those using medicines that affect renal perfusion or function (such as diuretics, angiotensin converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARBs], and possibly nonsteroidal anti–inflammatory drugs [NSAIDs]).

It is important to use the dose and dosing regimen as recommended (PM/AM split dose).

Please see full Prescribing Information for OsmoPrep, including BOXED WARNING.

OsmoPrep^® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. Considerable caution should be advised before OsmoPrep is used in patients with severe renal insufficiency, congestive heart failure, ascites, unstable angina, gastric retention, ileus, severe chronic constipation, bowel perforation, toxic megacolon, gastric bypass or stapling surgery, or hypomotility syndrome. Use with caution in patients with impaired renal function, patients with a history of seizures or at higher risk of seizure, patients with higher risk of cardiac arrhythmias, known or suspected electrolyte disturbances (such as dehydration), or people taking drugs that affect electrolyte levels. Patients with electrolyte abnormalities such as hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia should have their electrolytes corrected before treatment with OsmoPrep.

OsmoPrep is contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients, and in patients with biopsy–proven acute phosphate nephropathy. In clinical trials, the most commonly reported adverse reactions (reporting frequency >3%) were abdominal bloating, nausea, abdominal pain, and vomiting. It is recommended that patients receiving OsmoPrep be advised to adequately hydrate before, during, and after the use of OsmoPrep.